Form 4: GE HealthCare CTO Sells Shares for Tax Obligations

GE HealthCare Technologies Inc.'s Chief Technology Officer, Taha Kass-Hout, disposed of 2,897 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc. (GEHC), reported the disposition of common stock.
• The transactions occurred on September 1, 2025, and involved the withholding of shares to satisfy tax obligations in connection with the vesting of restricted stock units.
• A total of 2,897 shares were disposed of across two transactions: 1,601 shares and 1,296 shares.
• The shares were valued at $73.73 per share at the time of disposition.
• The total value of shares withheld for tax purposes was approximately $213,699.01.
• Following these transactions, Mr. Kass-Hout beneficially owns 64,950 shares of GE HealthCare common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is routine and for tax purposes, not a discretionary sale, which is generally viewed neutrally. The use of a 10b5-1 plan adds a slight positive for transparency and compliance.

Positives

• The transaction is a routine tax-related disposition, not a discretionary sale, indicating no change in investment sentiment from the officer.
• The transaction was executed under a Rule 10b5-1(c) plan, demonstrating pre-planned compliance and reducing concerns about opportunistic insider trading.

Negatives

• A reduction in direct beneficial ownership by a key executive, even if for tax purposes, slightly decreases the executive's direct equity stake in the company.

Future Outlook

This filing, an insider transaction report, does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction common across all industries when executives' restricted stock units vest, requiring shares to be withheld to cover tax liabilities. It does not reflect specific industry trends or competitive positioning within the healthcare technology sector.

Comparison to Industry Standards

• Such tax-related dispositions are standard practice for executive compensation across publicly traded companies, including those in the healthcare technology sector.
• There are no specific comparable companies, projects, or results mentioned as this is a personal transaction for tax purposes related to executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related transaction, not a discretionary sale indicating a change in executive confidence. The slight reduction in direct ownership is offset by the routine nature.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by a Chief Technology Officer to cover tax obligations upon the vesting of restricted stock units. This type of transaction, especially when executed under a Rule 10b5-1 plan, is a common occurrence and does not typically signal a change in the executive's confidence in the company's future prospects or fundamental performance. Therefore, it provides no new information that would warrant a change in an investor's current position, leading to a 'hold' recommendation.

Keywords

GE HealthCare Technologies, GEHC, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Tax Withholding, Taha Kass-Hout, Chief Technology Officer, 10b5-1 plan